In the context of market volatility, we are playing it safe and booking profits on two of our recommended stocks.
With the background of the recent rally, we are moving this auto play to a ‘HOLD’ so you don’t enter at high valuations.
Assessing management quality is a key input to screening stocks and R Balakrishnan gives us some red flags to watch out for while doing this.
Recent announcements relating to ownership change in this pharma stock prompt us to move this stock from a ‘BUY’ to a ‘HOLD’.
A report from Kotak Institutional Equities sparked a bout of selling in mid and small caps. Should you be concerned? Here is what we think.
As stocks across market caps have run up, we are taking a look at Prime Stocks with a special focus on valuations and are moving these two stocks to a ‘HOLD’.
Results update for 5 of our Prime Stocks.
This commodity stock is well placed to play the changing tide in the sector on account of its affordable valuations.
Results update for 5 of our Prime Stocks
Consolidation and correction have made stocks of affordable housing finance companies attractive and this is our pick in the space.
results update for 5 of our Prime Stocks
We are moving an industrial sector stock that we recommended in June 2022, to a HOLD.
Hold On
You are being redirected to another page,
Elevate Your Wealth with Professional Portfolio Management
